Desq Long
Sign in

Company

Neurogene Inc.

NGNE · CIK 0001404644

SEC FORM 4
$19,141.92

Neurogene Inc. (NGNE)

Acquisition (code M) of 756 shares at $25.32 per share.

Reporting Person McMinn Rachel · Officer Title Chief Executive Officer · Transaction Code M

Traded Sep 22, 2026 · Disclosed Oct 2, 2026FILED +10 DAYS

Source: SEC Form 4 · 0001606302-26-000007 · filed 2026-10-02 · View filing →